Latest Palpitation Stories
Study highlights: - Researchers report a more accurate way to detect and assess irregular heartbeats which can cause blood clots to form. - Using this new technology can help healthcare providers assess patients who do not experience symptoms related to the heart rhythm disturbance called atrial fibrillation. DALLAS, Feb.
Catheter treatment works dramatically better than drugs for common heart rhythm disorder.
Physicians at The Mount Sinai Medical Center in New York became the first in the U.S. to ablate atrial fibrillation using a visually-guided laser balloon catheter.
Only Hospital in Northern and Central California to Reach 1,000 A-Fib Ablations REDWOOD CITY, Calif., Sept.
The REVISE Study (Reveal in the Investigation of Syncope and Epilepsy) found that 1 in 8 adult patients in the United Kingdom, previously thought to be suffering from epilepsy or in whom this diagnosis was in doubt, in fact had symptoms as a result of an abnormal pattern of heart beating, commonly found in patients with syncope (fainting).
A new innovative approach to treating atrial fibrillation (A-Fib) is showing improved results over the common drug treatment.
Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, a major international study has found.
Predictors of atrial fibrillation (AF or afib) might offer physicians a better way to prevent stroke in blacks, according to a new study done by researchers at Wake Forest University School of Medicine.
The U.S. Food and Drug Administration announced a recall of Influend-brand cough and cold products sold in Alabama on or after May 30 due to a health risk. The FDA said ION Labs Inc.
Retrospective Analysis Presented at 58th Annual Scientific Session of the American College of Cardiology Suggests Oral Anticoagulants are Underused in Eligible Patients with Non-Valvular Atrial Fibrillation at Risk for Stroke RIDGEFIELD, Conn., March 31 /PRNewswire/ -- Boehringer Ingelheim today announced that it plans to launch REAL-AF (Registry to Evaluate AnticoaguLation in Atrial Fibrillation), a U.S.